timothy sykes logo

Stock News

Dermata Therapeutics: Unveiling Bold Moves

Tim SykesAvatar
Written by Timothy Sykes Reviewed by Bryce Tuohey Fact-checked by Matt Monaco
Updated 12/30/2025, 9:18 am ET 12/30/2025, 9:18 am ET | 5 min 5 min read
Dermata Therapeutics: Unveiling Bold Moves Thumbnail

Dermata Therapeutics Inc.’s stocks have been trading up by 26.34 percent, fueled by positive FDA designations and results.

  • A forthcoming once-weekly acne kit is anticipated by mid-2026, marking a bold step in their OTC skincare business and potentially shaking up the dermatology industry.

  • The company has initiated a private placement of over 2M shares at $2.04, gearing up to raise $4.1M, with significant insider participation, and aiming for $8.3M if all warrants are exercised by Dec 29.

Candlestick Chart

Live Update At 09:18:03 EST: On Tuesday, December 30, 2025 Dermata Therapeutics Inc. stock [NASDAQ: DRMA] is trending up by 26.34%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Overview: Financial Health and Market Prospects

One key lesson for traders is to avoid holding onto hopes in the midst of a losing trade. By cutting losses early, potential greater losses can be prevented. It’s crucial for traders to remain disciplined and not let emotions drive their decisions. As millionaire penny stock trader and teacher Tim Sykes, says, “It’s better to go home at zero than to go home in the red.” This means that instead of risking more in hopes of reclaiming losses, it’s wiser to exit at break-even or minimal losses and reassess the strategy. By adhering to this principle, traders can safeguard their funds and make more informed decisions in the future.

Dermata Therapeutics has been active with financial maneuvers, as highlighted by its recent endeavors to bolster cash reserves through private placements. The cash position shifted from around $6.5M to $4.7M, reflecting the impact of operating expenses and strategic activities. With operating cash flows in the negative bracket, it is evident that the company is intensifying its efforts to manage costs and gear up for future growth initiatives.

The financial reports depict a company balancing on an innovation tightrope. While Dermata’s current ratio stands strong at 4.6, indicating good short-term liquidity, the absence of total debt reflects a strategic choice to portfolio management sans leverage. However, profitability metrics paint a grave narrative—return on assets is deeply negative at -150.49%, sliding over a timeline of operational investments into scientific advancements.

Seeing this through a potential investor’s eyes, the company is steering through turbulent waters, bearing the weight of expenses against nascent revenue streams. The market anticipates profitability through their new skincare launch, suggesting that Dermata’s valuation could hinge greatly on the mid-2026 product deployment and its market reception.

The Story Behind Stock Fluctuations

The recent series of announcements, including strategic financial planning and targeted product innovation, drive a concoction of anticipatory buzz across investment forums. Dermata’s stock price, moving between $1.86 to $2.69 in recent days, mirrors investor sentiment oscillating between cautious optimism and skepticism.

The unveiling of a new skincare brand and impending product launch aligns with attempts to disrupt the current market scene. This infusion of science mixed with time-tested practices pokes curiosity, expected to jolt consumer interest and investor enthusiasm alike. However, the stock behavior appears tied to the concluding steps of the private placement offer, which echoes louder than the usual market humdrum.

More Breaking News

Conclusion: We’ll See Where the Dice Land

In conclusion, Dermata Therapeutics is plotting a path underpinned by modern innovation and strategic market plays. Even as it bets heavily on a scientifically-grounded brand reformation, the financial chessboard includes ensuring liquidity through private placements—a cautious yet calculated maneuver. As millionaire penny stock trader and teacher Tim Sykes says, “It’s better to go home at zero than to go home in the red.” This cautionary wisdom resonates as the company navigates this balance between ambition and risk. How these moves interplay will ultimately guide trader decisions as to whether this underdog emerges a conqueror or stumbles in the weighty footsteps of its ambitions. Hence, all eyes will remain keenly fixed on its upcoming outreach campaign, assessing the tangible impact of these bold strategies.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Tim Sykes

Head Writer at TimothySykes.com, Lead Mentor at the Trading Challenge
In his 20-plus years of trading, Tim has made $7.9 million. In his 15-plus years of teaching, Tim’s Trading Challenge has produced over 30 millionaire students. His philosophy emphasizes small gains and cutting losses quickly.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”